Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Bioorganic Chemistry|July 20, 2023
Design, synthesis, and biological evaluation of novel molecules as potent inhibitors of PLK1Jing Lu, Hui Lei, Xinfa Bai, et al.
Journal of Medicinal Chemistry|March 31, 2025
Rational Design of the First Dual Agonist at Trace Amine-Associated Receptor 1 and 5-HT<sub>2C</sub> Receptors Based on Binding Pocket Similarity for the Treatment of Schizophrenia and Alzheimer's Disease-Related PsychosisJing Lu, Pengfei Yu, Yunjie Wang, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 18, 2022
Neonatal exposure to sevoflurane induces adolescent neurobehavioral dysfunction by interfering with hippocampal glycerophoslipid metabolism in ratsYonghai Wang, Hongchun Li, Ying Zhao, et al.
Neuropharmacology|March 27, 2026
Ciprofloxacin Exposure Impairs Neurogenesis and E/I balance in Human Cortical OrganoidsHaxiaoyu Liu, Linhong Jiang, Qian Bu, et al.
Cell Biology and Toxicology|August 30, 2021
Integrated lipidomic and transcriptomic analysis reveals clarithromycin-induced alteration of glycerophospholipid metabolism in the cerebral cortex of miceXiaojie Wang, Liang Wang, Mingyi Luo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 8, 2021
4R Tau Modulates Cocaine-Associated Memory through Adult Dorsal Hippocampal NeurogenesisHongchun Li, Wei Xu, Denian Wang, et al.
Genomics, Proteomics & Bioinformatics|May 20, 2023
Morphine Re-arranges Chromatin Spatial Architecture of Primate Cortical NeuronsLiang Wang, Xiaojie Wang, Chunqi Liu, et al.
Communications Biology|April 24, 2021
Structure and function analysis of a potent human neutralizing antibody CA521<sup>FALA</sup> against SARS-CoV-2Deyong Song, Wenbo Wang, Chuangchuang Dong, et al.
Cell Reports|November 30, 2022
β-hydroxybutyrate reduces reinstatement of cocaine conditioned place preference through hippocampal CaMKII-α β-hydroxybutyrylationHongchun Li, Xuemei Wan, Zhixiang Wu, et al.
Translational Psychiatry|May 10, 2023
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorderWeifeng Mi, Xiaolan Di, Yiming Wang, et al.
Pageof 19